Atai Life Sciences N.V.

NASDAQ: ATAI
$3.79
+$0.14 (+3.8%)
Closing price June 24, 2022
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.